DRUGS CONTROLLER GENERAL OF INDIA
COVID-19 Vaccination Update: Govt Panel Recommends Permission for Phase-3 Trial of Covovax as Booster Dose in Adults
COVID-19 Vaccine Update: Govt Panel Recommends Permission For Phase 3 Trial of Sputnik Light Vaccine as Booster Dose
COVID-19 Vaccine: DGCI Gives Nod to SII’s Proposal To Manufacture Vaccine Against Omicron for Test, Analysis
COVID-19 Vaccine Update: DCGI Grants Emergency Use Permission to Single-Dose Sputnik Light Vaccine
Molnupiravir Capsules: Dr Reddy's Laboratories Gets DCGI's Nod to Launch Oral Anti-Viral Drug in India For Treatment of Adult Patients With COVID-19
Sun Pharma to Introduce MSD, Ridgeback's Molnupiravir Under Brand 'Molxvir' in India For COVID-19 Treatment in Adults; DCGI Reviewing Clinical Data
ZyCoV-D Vaccine Update: Zydus Cadila Vaccine to Be Inoculated Through Applicator, Not Injection, Says Dr VK Paul
Cipla Gets DCGI Nod to Import Moderna's COVID-19 Vaccine for Restricted Emergency Use in India, Say Sources
Covaxin Phase 3 Trial Data: DCGI’s Expert Panel Says Bharat Biotech’s Vaccine 77.8% Effective
Bharat Biotech’s COVID-19 Vaccine COVAXIN Shows 77.8% Efficacy in Phase III Trials, Say Sources
Google Trends